Thu. 22 Feb 2024, 4:02pm ET
Benzinga
Earnings, Earnings Beats, News
Dynavax Technologies (NASDAQ:DVAX) reported quarterly sales of $55.60 million which beat the analyst consensus estimate of $52.73 million by 5.44 percent. This is a 69.87 percent decrease over sales of $184.49 million the same period last year.